Acute lithium intoxication and neuroleptic malignant syndrome

Pharmacotherapy

Volumn 23, Issue 6, 2003, Pages 811-815

  Gill, Jasleen ^a   Singh, Harmohan ^b   Nugent, Kenneth ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CREATININE; LITHIUM;

ACUTE KIDNEY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CASE REPORT; CAUCASIAN; CONFUSION; CREATININE BLOOD LEVEL; DRUG INTOXICATION; DRUG OVERDOSE; FEVER; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; LITHIUM BLOOD LEVEL; MALE; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; RHABDOMYOLYSIS; SELF POISONING; SUSTAINED RELEASE PREPARATION; TABLET; TACHYPNEA;

ANTIPSYCHOTIC AGENTS; FATAL OUTCOME; HUMANS; KIDNEY FAILURE, ACUTE; LITHIUM; MALE; MIDDLE AGED; NEUROLEPTIC MALIGNANT SYNDROME;

EID: 0038350756     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.23.6.811.32179     Document Type: Article

References (29)

1. Schou M. Clinical aspects of lithium in psychiatry. In: Birch NJ, ed. Lithium and the cell: pharmacology and biochemistry. New York: Academic Press, 1991:1-6.
2. Davis JM, Janowsky DS, el-Yousef MK. The use of lithium in clinical psychiatry. Psych Annals 1973;3(2):78-98.
3. Manji HK, Potter WZ, Lenox RH. Signal transduction pathways: molecular targets for lithium's actions. Arch Gen Psychiatry 1995;52:531-43.
4. Kondziela J. Extreme lithium intoxication without severe symptoms. Hosp Comm Psychiatry 1984;35:727-8.
5. Kluge H, Waldmann K, Gregor J. Lithium distribution in organs after lithium poisoning. Psychiatr Clin (Basel) 1978;11:98-9.
6. Clendeninn NJ, Pond SM, Kaysen G, Barraza JJ, Farrell T, Bocker CE. Potential pitfalls in the evaluation of the usefulness of hemodialysis for the removal of lithium. J Toxicol B Clin Toxicol 1982;19:341-52.
7. Groleau G. Lithium toxicity. Emerg Med Clin North Am 1994;12:511-31.
8. Kores B, Lader MH. Irreversible lithium neurotoxicity: an overview. Clin Neuropharmacol 1997;20:283-9.
9. Unger J, Decaux G, EHermite M. Rhabdomyolysis, acute renal failure, endocrine alterations and neurological sequelae in a case of lithium self poisoning. Acta Clinica Belgica 1982;37:216-33.
10. Apte SN, Langston JW. Permanent neurological deficits due to lithium toxicity. Ann Neurol 1983;13:453-5.
11. Von Hartitzsch B, Hoenich NA, Leigh RJ, et al. Permanent neurological sequelae despite hemodialysis for lithium intoxication. Br Med J 1972;4(843):757-9.
12. Fava GA, Grandi S. Withdrawal syndromes after paroxetine and sertraline discontinuation [letter]. J Clin Psychopharmacol 1995;15:374-5.
13. Noveske FG, Hahn KR, Flynn RJ. Possible toxicity of combined fluoxetine and lithium [letter]. Am J Psychiatry 1989;146:1515.
14. Mason PG, Morris VA, Balcezak TJ. Serotonin syndrome: presentation of two cases and review of the literature. Medicine 2000;79:201-9.
15. Heyland D, Sauve M. Neuroleptic malignant syndrome without the use of neuroleptics. Can Med Assoc J 1991;145:817-19.
16. Pearlman C. Neuroleptic malignant syndrome: a review of the literature. J Clin Psychopharmacol 1986;6:257-73.
17. Halman M, Goldbloom DS. Fluoxetine and neuroleptic malignant syndrome. Biol Psychiatry 1990;28:518-21.
18. Behan WMH, Madigan M, Clark BJ, Goldberg J, McLellan DR. Muscle changes in the neuroleptic malignant syndrome. J Clin Pathol 2000;53:223-7.
19. Cohen WJ, Cohen NH. Lithium carbonate, haloperidol and irreversible brain damage. JAMA 1974;230:1283-7.
20. Rosebush P, Stewart T. A prospective analysis of 24 episodes of neuroleptic malignant syndrome. Am J Psychiatry 1989;146:717-25.
21. Lin PY, Wu CK, Sun TF. Concomitant neuroleptic malignant syndrome and lithium intoxication in a patient with bipolar I disorder: case report. Changgeng Yi Xue Zhi 2000;23:624-9.
22. Spring G, Frankel M. New data on lithium and haloperidol incompatibility. Am J Psychiatry 1981;138:818-21.
23. Koehler PJ, Mirandolle JF. Neuroleptic malignant-like syndrome and lithium [letter]. Lancet 1988;2(8626-27):1499-500.
24. Susman VL, Addonizio G. Reinduction of neuroleptic malignant syndrome by lithium. J Clin Psychopharmacol 1987;7:339-41.
25. Gupta S, Racaniello AA. Neuroleptic malignant syndrome associated with amoxapine and lithium in an older adult. Ann Clin Psychiatry 2000;12:107-9.
26. Fava S, Galizia AC. Neuroleptic malignant syndrome and lithium carbonate. J Psychiatry Neurosci 1995;20:305-6.
27. Rosebush PI, Stewart T, Mazurek MF. The treatment of neuroleptic malignant syndrome. Are dantrolene and bromocriptine useful adjuncts to supportive care? Br J Psychiatry 1991;159:709-12.
28. Rose SR, Klein-Schwartz W, Oderda GM, Gorman RL, Young WW. Lithium intoxication with acute renal failure and death. Drug Intell Clin Pharm 1988;22:691-4.
29. Timmer RT, Sands JM. Lithium intoxication. J Am Soc Nephrol 1999;10:666-74.